Gastroesophageal cancers are cancers that begin in the esophagus and the stomach. They are typically diagnosed at a late stage, so they present a poor prognosis. Esophageal cancers typically begin in the bottom portion of the esophagus, and affect more men than women. Risk factors include: older age, poor diet, drinking alcohol, obesity, gastroesophageal reflux disease, smoking, chewing tobacco, and radiation treatment to the chest or upper abdomen. Treatments include surgery, chemotherapy, radiation, and clinical trials. Gastric (stomach) cancers begin in the upper part of the stomach. Risk factors for stomach cancer include smoking, stomach polyps, poor diet, long term stomach inflammation, or various stomach infections. Treatments are the same as for esophagus cancer.
Gastrooesophageal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Gastrooesophageal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 3289 products for the study of Gastrooesophageal Cancer that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.